ReviewCurrent hematologic malignancy reports2020
Brentuximab Vedotin in the Treatment of Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma.
Lauren Shea et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it